Ovarian Cancer Survival and Chemotherapy Dosing, Body Mass Index, and Body Surface Area : Are We There Yet?

JAMA Oncol. 2015 Sep;1(6):732-3. doi: 10.1001/jamaoncol.2015.1926.

Authors

S Percy Ivy¹, Jan H Beumer²

Affiliations

¹ Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
² Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania3Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Body Mass Index*
Cisplatin / administration & dosage*
Drug Dosage Calculations*
Humans
Neoplasms, Glandular and Epithelial / drug therapy*
Obesity / complications*
Ovarian Neoplasms / drug therapy*
Paclitaxel / administration & dosage*

Substances

Paclitaxel
Cisplatin

Grants and funding